Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain
Status:
Recruiting
Trial end date:
2023-12-28
Target enrollment:
Participant gender:
Summary
Analysis of the efficacy, maintenance of efficacy, long-term safety, and investigation of the
potential for dependence and abuse and the effect of abrupt drug withdrawal of VER-01 in the
treatment of patients with chronic non-specific low back pain when drug treatment is
indicated and previous optimised treatments with non-opioid analgesics have not led to
sufficient pain relief or were unsuitable due to contraindications or intolerance.